Prestige Consumer Healthcare director reports 3,000-share stock sale

Rhea-AI Filing Summary

Prestige Consumer Healthcare Inc. (PBH) director John E. Byom reported a sale of company stock. On 11/25/2025, he sold 3,000 shares of common stock at a price of $59.35 per share in a single reported transaction where multiple lots at the same price were combined. After this sale, he beneficially owns 51,594 shares, held directly. The filing is made on Form 4, which reports changes in the ownership of company equity by an insider who serves as a director.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BYOM JOHN E

(Last) (First) (Middle)

660 WHITE PLAINS ROAD

(Street)

TARRYTOWN NY 10591

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Prestige Consumer Healthcare Inc. [ PBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	11/25/2025		S		3,000(1)	D	$59.35	51,594	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Multiple lots for the same price for this transaction have been combined.

	/s/ John E. Byom by William P'Pool Attorney-in-Fact pursuant to Power of Attorney dated May 8, 2017 on file with the Commission	11/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Prestige Consumer Healthcare (PBH) report?

Prestige Consumer Healthcare reported that director John E. Byom sold 3,000 shares of common stock on 11/25/2025.

At what price were the PBH shares sold in this Form 4 filing?

The director sold the 3,000 PBH shares at a price of $59.35 per share.

How many Prestige Consumer Healthcare (PBH) shares does the director own after the sale?

Following the reported transaction, the director beneficially owns 51,594 PBH shares, held in direct ownership.

What is the insider’s relationship to Prestige Consumer Healthcare (PBH)?

The reporting person in this Form 4 is a director of Prestige Consumer Healthcare Inc. (PBH).

Does the Form 4 indicate multiple trade lots for the PBH share sale?

Yes. The explanation notes that multiple lots for the same price in this transaction have been combined for reporting purposes.

Is this Prestige Consumer Healthcare (PBH) Form 4 filed for one or multiple reporting persons?

The document states that the Form 4 is filed by one reporting person, not by a group.